Skip to content

Clinical trials

Graves Ophthalmopathy trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Graves Ophthalmopathy Country / region: United States Clear all

52 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20133
20141
20161
20173
20181
20191
20202
20213
20225
20237
202411
20253
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Terminated9
Recruiting8
Active, not recruiting6
Not yet recruiting3
Approved for marketing1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen12
Viridian Therapeutics, Inc.9
Immunovant Sciences GmbH4
Sling Therapeutics, Inc.3
Hoffmann-La Roche2
Johns Hopkins University2
Minghui Pharmaceutical (Hangzhou) Ltd2
THYROSCOPE INC.2
argenx2
ACELYRIN Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Graves Ophthalmopathy52
Graves Disease10
Exophthalmos8
Eye Diseases5
Thyroid Diseases4
Autoimmune Diseases3
Endocrine System Diseases3
Hashimoto Disease3
Orbital Diseases3
Hyperthyroidism2

Trials

Showing 1 to 25 of 52. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.